Friday Feb 10 | Freshnews
XenoPort to Present at the Leerink Swann Global Healthcare Conference
XenoPort, Inc. announced today that it will provide access via the World Wide Web to its presentation at the Leerink Swann Global Healthcare Conference.
XenoPort to Release Fourth Quarter and Year-End Financial Results on February 14, 2012
XenoPort, Inc. announced today that it will release its fourth quarter financial results on February 14, 2012 at approximately 4:30 p.m. Eastern Time.
Healthcare Sector Review: Bristol-Myers Squibb Warning, NuVasive's Injunction Update
NuVasive, Inc. : A hearing on Medtronic's petition for an injunction against NuVasive is slated to be held tomorrow, January 26.
UPDATE 1-XenoPort says Glaxo breached Horizant contract
XenoPort Inc said its partner GlaxoSmithKline Plc has breached a contractual obligation to maximise the sales of their drug to treat restless legs syndrome and achieve a sales milestone.
4 Low-Priced Biotech Stocks Poised To Rally In 2012
Earlier this month, Bristol-Myers agreed to buy Inibitex, Inc. for $26 per share.